Treatment Options for Vertigo
The primary evidence-based treatments for vertigo depend on the underlying cause, with canalith repositioning procedures (Epley or Semont maneuver) being the first-line treatment for benign paroxysmal positional vertigo (BPPV), while medications like meclizine (25-100 mg daily) are indicated for vertigo associated with vestibular system diseases. 1, 2
Diagnostic Classification to Guide Treatment
Before initiating treatment, it's essential to classify vertigo based on its cause:
Peripheral Causes (most common in primary care):
- Benign Paroxysmal Positional Vertigo (BPPV) - 42% of cases
- Vestibular Neuritis - 41% of cases
- Ménière's Disease - 10% of cases
Central Causes:
- Vestibular Migraine - up to 14% of cases
- Vascular causes - 3% of cases
Treatment Approaches by Specific Condition
1. Benign Paroxysmal Positional Vertigo (BPPV)
- First-line treatment: Canalith repositioning procedures (CRPs)
- Epley or Semont maneuver (80-90% success rate after 1-2 treatments) 1
- These procedures should be performed before considering medication
- Adjunct therapy: Vestibular rehabilitation exercises (particularly beneficial for elderly patients)
- Important: The American Academy of Otolaryngology-Head and Neck Surgery recommends against routinely using vestibular suppressant medications for BPPV 1
2. Vestibular Neuritis/Labyrinthitis
- Acute phase treatment:
- Short course of oral corticosteroids (prednisone or methylprednisolone) for 7-14 days with tapering dose 1
- Vestibular suppressants for symptom control only during acute phase
- Recovery phase: Vestibular rehabilitation exercises to promote compensation
3. Ménière's Disease
- First-line therapy: Low-salt diet combined with diuretics (reduces vertigo attacks by 56% compared to placebo) 1
- For acute attacks: Vestibular suppressants and antiemetics
- Refractory cases: Transtympanic gentamicin for patients with non-usable hearing 1
4. Vestibular Migraine
- Prophylactic treatment: Beta-blockers, anticonvulsants, or antidepressants 1
- Acute attacks: Similar management to other migraines
Pharmacological Options
1. Vestibular Suppressants
- Meclizine (FDA-approved for vertigo):
2. Other Medication Options
Antiemetics:
Benzodiazepines (e.g., lorazepam):
- For acute symptom control
- Caution: Long-term use can delay vestibular compensation 1
Important Clinical Considerations
- Avoid prolonged use of vestibular suppressants as they can delay central compensation and recovery 1
- Reassess patients within 1 month after initial treatment to confirm symptom resolution 1
- Avoid unnecessary imaging unless diagnosis is uncertain or additional symptoms warrant testing 1
- Patient education is crucial:
- Explain mechanism of vertigo
- Discuss fall prevention strategies
- Review warning signs requiring further evaluation
- Provide reassurance about generally favorable prognosis
- Explain possibility of recurrence (10-18% at 1 year, up to 36% long-term for BPPV) 1
Special Considerations
- Elderly patients are at higher risk for falls; home safety assessment is crucial 1
- Patients with asthma, glaucoma, or prostate enlargement should use meclizine with caution due to potential anticholinergic effects 2
- Drug interactions: Meclizine may increase CNS depression when used with other CNS depressants, including alcohol 2
Remember that most vertigo cases in primary care are benign peripheral causes that can be effectively managed with appropriate treatment, and many will resolve with time and proper management.